Left atrial fibrosis quantification by late gadolinium-enhanced magnetic resonance: a new method to standardize the thresholds for reproducibility

2008, Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation, J Am Coll Cardiol, 51, 802, 10.1016/j.jacc.2007.09.064

2013, Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy, Eur Heart J, 34, 2731, 10.1093/eurheartj/eht194

2015, Cardiac MRI: a central prognostic tool in myocardial fibrosis, Nat Rev Cardiol, 12, 18, 10.1038/nrcardio.2014.159

2014, Use of MRI to guide electrophysiology procedures, Heart, 100, 1975, 10.1136/heartjnl-2013-304692

2016, Use of delayed-enhancement magnetic resonance imaging for fibrosis detection in the atria: a review, Europace, 19, 180

2009, Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation, Circulation, 119, 1758, 10.1161/CIRCULATIONAHA.108.811877

2014, Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study, JAMA, 311, 498, 10.1001/jama.2014.3

2014, CMR-guided approach to localize and ablate gaps in repeat AF ablation procedure, JACC Cardiovasc Imaging, 7, 653, 10.1016/j.jcmg.2014.01.014

2014, Magnetic resonance image intensity ratio, a normalized measure to enable interpatient comparability of left atrial fibrosis, Heart Rhythm, 11, 85, 10.1016/j.hrthm.2013.10.007

2015, Clinical value of assessment of left atrial late gadolinium enhancement in patients undergoing ablation of atrial fibrillation, Int J Cardiol, 179, 351, 10.1016/j.ijcard.2014.11.072

2013, Diagnostic accuracy of cardiac magnetic resonance imaging in the detection and characterization of left atrial catheter ablation lesions: a multicenter experience, J Cardiovasc Electrophysiol, 24, 396, 10.1111/jce.12063

2016, Expert consensus document: defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment, Nat Rev Cardiol, 13, 230, 10.1038/nrcardio.2015.194

2015, Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study, Circ Cardiovasc Imaging, 8, e002769, 10.1161/CIRCIMAGING.114.002769

2014, Delineating atrial scar by electroanatomic voltage mapping versus cardiac magnetic resonance imaging: where to draw the line?, J Cardiovasc Electrophysiol, 25, 1053, 10.1111/jce.12481

2014, Cardiac magnetic resonance and electroanatomical mapping of acute and chronic atrial ablation injury: a histological validation study, Eur Heart J, 35, 1486, 10.1093/eurheartj/eht560

2015, Repeat left atrial catheter ablation: cardiac magnetic resonance prediction of endocardial voltage and gaps in ablation lesion sets, Circ Arrhythm Electrophysiol, 8, 270, 10.1161/CIRCEP.114.002066

2014, Comparison of left atrial area marked ablated in electroanatomical maps with scar in MRI, J Cardiovasc Electrophysiol, 25, 457, 10.1111/jce.12357

2012, Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications, J Hum Hypertens, 26, 563, 10.1038/jhh.2011.105

2013, Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium, J Am Heart Assoc, 2, e000102, 10.1161/JAHA.112.000102

2016, Contact force threshold for permanent lesion formation in atrial fibrillation ablation: a cardiac magnetic resonance-based study to detect ablation gaps, Heart Rhythm, 13, 37, 10.1016/j.hrthm.2015.08.010

2015, MRI assessment of ablation-induced scarring in atrial fibrillation: analysis from the DECAAF study, J Cardiovasc Electrophysiol, 26, 473, 10.1111/jce.12650